The Neuroscience of Emotion: Amygdala Fear Circuits, Prefrontal Emotion Regulation, and the Neural Mechanisms of Traumatic Memory

The Neuroscience of Emotion: Amygdala Fear Circuits, Prefrontal Regulation, and Traumatic Memory

Contemporary research (Lisa Feldman Barrett) challenges the classical view of a dedicated “limbic system” for emotion, arguing emotions are actively constructed by distributed brain networks based on interoception, memory, and prediction — not fixed hardwired circuits.

## The Amygdala’s Role in Fear and Threat Processing

The **amygdala** is the most deeply studied structure in emotion neuroscience. Joseph LeDoux’s classic research describes two fear information pathways: **Low Road** — sensory thalamus → amygdala (fast but crude, triggering defensive responses before cortical processing); **High Road** — sensory thalamus → sensory cortex → amygdala (slow but accurate, allowing contextual evaluation). This explains why we jump before realizing the ground object is a stick rather than a snake — the amygdala’s “low road” precedes cortical analysis.

**Amygdala damage** cases (e.g., Urbach-Wiethe disease causing bilateral amygdala calcification): patients cannot learn fear conditioning, cannot recognize fearful expressions, and lack normal avoidance responses in dangerous situations — directly proving the amygdala’s irreplaceable fear processing role.

## Traumatic Memory and PTSD Neural Mechanisms

**PTSD**’s characteristic symptoms (flashbacks, nightmares, hypervigilance) reflect abnormal neural encoding of traumatic memories: massive adrenaline and norepinephrine release during trauma over-activates the amygdala, “over-consolidating” the emotional component of episodic memories (while narrative context and time markers are relatively weakened). One EMDR neural mechanism hypothesis: eye movements induce a REM-sleep-like neural state, helping traumatic memories be reprocessed into ordinary (de-emotionalized) memories integrated into autobiographical narrative.

上一篇 AI用于数据管理计划:满足资助方要求而不必从头开始
下一篇 Anti-Aging Drug Pipeline: From Rapamycin to GLP-1, Which Treatments Could Extend Healthspan